Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sattanathan Paramasivan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|July 30, 2008
Mix and measure fluorescence screening for selective quadruplex bindersSattanathan Paramasivan, Philip H Bolton
Methods (San Diego, Calif.)|October 31, 2007
Circular dichroism of quadruplex DNAs: applications to structure, cation effects and ligand bindingSattanathan Paramasivan, Iulian Rujan, Philip H Bolton
Nature Biomedical Engineering|April 25, 2019
Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugsMatthew R Golder, Jenny Liu, Jannik N Andersen, et al.
Nature Biomedical Engineering|March 29, 2019
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugsMatthew R Golder, Jenny Liu, Jannik N Andersen, et al.
Journal of the American Chemical Society|March 19, 2021
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|July 30, 2008
Mix and measure fluorescence screening for selective quadruplex bindersSattanathan Paramasivan, Philip H Bolton
Methods (San Diego, Calif.)|October 31, 2007
Circular dichroism of quadruplex DNAs: applications to structure, cation effects and ligand bindingSattanathan Paramasivan, Iulian Rujan, Philip H Bolton
Nature Biomedical Engineering|April 25, 2019
Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugsMatthew R Golder, Jenny Liu, Jannik N Andersen, et al.
Nature Biomedical Engineering|March 29, 2019
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugsMatthew R Golder, Jenny Liu, Jannik N Andersen, et al.
Journal of the American Chemical Society|March 19, 2021
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.
Pageof 1